Silibinin is a STAT3 inhibitor which seems to have an adjuvant role in antitumor pathways, although its own molecular mechanism against cancer cells remains not fully explained: it could probably decrease the tumor volume and delay the tumor tissue development. This evidence concerns the gene STAT3 and cancer.